Our latest Neuro Pathways podcast explores observed gender differences in PD and shares how we’re using a novel female-tailored patient questionnaire to better understand the disease in women.
Read MorePatterns of DNA Methylation May Differentiate Indolent and Aggressive Prostate Cancers
Differences between indolent and aggressive forms of prostate cancer have been identified based on patterns of DNA methylation according to researchers Lerner Research Institute of the Cleveland Clinic.
Genetics at the Forefront
Charis Eng, MD, PhD, Chair and Director of Cleveland Clinic’s Genomic Medicine Institute, shares her views on genetics-related Top 10 Innovations.
Family Medical History Influences Patient Health
Recording patients’ family medical history and including it in their medical record is important in prevention, risk reduction and early detection of disease.
Genetic Testing for Your Patients: Navigating the Complexities
As key members of the Center for Personalized Genetic Healthcare, genetic counselors translate complicated data into information patients can readily understand.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Cleveland Clinic Unveils Top 10 Medical Innovations For 2016
Cleveland Clinic physicians and scientists release annual Top 10 innovations list, including faster methods of creating vaccines, a process for rewriting genetic code and a water purification system for the developing world.
The New Way to Train Future Doctors
In just the past decade or two, healthcare has undergone tremendous change. We don’t expect it to let up. The change will continue, and it has forced us to rethink the way that we educate the next generation of doctors.
Genomics-Driven Clinical Trials Scarce in Cancer Therapy
Precision medicine matches a tumor’s unique genetic information with a targeted therapeutic and can be highly effective — provided the therapy is available. Often it isn’t.
Getting Personalized: Therapeutic Targeting of Brain Tumors Gets Smarter Through Genomics
Many patients with glioblastoma or meningioma at Cleveland Clinic are now offered genomic profiling of their tumors. Here’s why, along with a glimpse of where the practice is taking brain tumor therapy.